{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:57:38Z","timestamp":1776895058450,"version":"3.51.2"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejps.2025.107354","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:11:41Z","timestamp":1761783101000},"page":"107354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Blood-brain barrier permeability revisited: Predicting intrinsic passive BBB permeability using the Solubility-diffusion model"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-0259","authenticated-orcid":false,"given":"Andrea","family":"Ebert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Uwe","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107354_bib0001","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-3565(25)12379-3","article-title":"Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives","volume":"276","author":"Abbruscato","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0002","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0022-3565(25)12397-5","article-title":"Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter","volume":"276","author":"Adkison","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0003","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1471-4159.2001.00093.x","article-title":"Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique","volume":"76","author":"Allen","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107354_bib0004","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/jcbfm.2009.54","article-title":"Clonidine transport at the mouse blood-brain barrier by a new H antiporter that interacts with addictive drugs","volume":"29","author":"Andr\u00e9","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2025.107354_bib0005","series-title":"Absorption and Drug Development: Solubility, Permeability, and Charge State","article-title":"Absorption and drug development: solubility, permeability, and charge state","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.ejps.2025.107354_bib0006","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11095-010-0298-0","article-title":"A new in situ brain perfusion flow correction method for lipophilic drugs based on the pH-dependent crone-renkin equation","volume":"28","author":"Avdeef","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC. Neurol."},{"key":"10.1016\/j.ejps.2025.107354_bib0008","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1073\/pnas.87.17.6762","article-title":"Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin","volume":"87","author":"Banks","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2025.107354_bib0009","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0361-9230(89)90186-X","article-title":"Passage of Tyr-MIF-1 from blood to brain","volume":"23","author":"Barrera","year":"1989","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejps.2025.107354_bib0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS. J."},{"key":"10.1016\/j.ejps.2025.107354_bib0011","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat","volume":"278","author":"Bickel","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0012","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1471-4159.2007.04808.x","article-title":"Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec\u00ae) across the mouse blood-brain barrier","volume":"102","author":"Bihorel","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107354_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0190319","article-title":"Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: a mechanistic model","volume":"12","author":"Bittermann","year":"2017","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2025.107354_bib0014","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","article-title":"Evidence for an active transport of morphine-6-\u03b2-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier","volume":"86","author":"Bourasset","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107354_bib0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jcbfm.2014.71","article-title":"The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure","volume":"34","author":"Chen","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejps.2025.107354_bib0016","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.102.037143","article-title":"Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model","volume":"303","author":"Chen","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0017","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(25)09541-2","article-title":"The effect of verapamil on the transport of peptides across the blood- brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism","volume":"273","author":"Chikhale","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0018","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-03-2033","article-title":"Expression, Up-Regulation, and Transport Activity of the Multidrug-Resistance Protein Abcg2 at the Mouse Blood-Brain Barrier","volume":"64","author":"Cisternino","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0019","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1011080418027","article-title":"Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice","volume":"18","author":"Cisternino","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1023\/B:PHAM.0000036911.49191.da","article-title":"In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier","volume":"21","author":"Cisternino","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0021","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1023\/A:1026187301648","article-title":"In Vivo Saturation of the Transport of Vinblastine and Colchicine by P-Glycoprotein at the Rat Blood-Brain Barrier","volume":"20","author":"Cisternino","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0022","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1023\/A:1023895404929","article-title":"Apparent lack of mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells","volume":"20","author":"Cisternino","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0023","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2009.06.009","article-title":"P-glycoprotein deficient mouse in situ blood-brain barrier permeability and its prediction using an in combo PAMPA model","volume":"38","author":"Dagenais","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0024","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(01)01640-8","article-title":"Uptake and efflux of the peptidic delta-opioid receptor agonist","volume":"301","author":"Dagenais","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2025.107354_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bcp.2003.08.027","article-title":"Variable modulation of opioid brain uptake by P-glycoprotein in mice","volume":"67","author":"Dagenais","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107354_bib0026","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1023\/A:1010984110732","article-title":"Effect of mdr1a p-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds","volume":"18","author":"Dagenais","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106720","article-title":"Predicting the intrinsic membrane permeability of Caco-2\/MDCK cells by the solubility-diffusion model","volume":"195","author":"Dahley","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107280","article-title":"Predicting Caco-2\/MDCK intrinsic membrane permeability from HDM-PAMPA-derived hexadecane\/water partition coefficients","volume":"214","author":"Dahley","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106592","article-title":"Revisiting the pKa-Flux method for determining intrinsic membrane permeability","volume":"191","author":"Dahley","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-004-1377-8","article-title":"Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology","volume":"25","author":"Deli","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejps.2025.107354_bib0031","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107354_bib0032","unstructured":"EAS-E Suite, 2025. (Ver.0.98 - BETA, release April, 2025) [WWW Document]. Dev. by ARC Arnot Res. Consult. Inc., Toronto, ON, Canada. URL www.eas-e-suite.com. Accessed [02.05.2025]."},{"key":"10.1016\/j.ejps.2025.107354_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106819","article-title":"Can membrane permeability of zwitterionic compounds be predicted by the solubility diffusion model?","author":"Ebert","year":"2024","journal-title":"Eur. J. Pharm. Sci. Under Revi."},{"key":"10.1016\/j.ejps.2025.107354_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106699","article-title":"Pitfalls in evaluating permeability experiments with Caco-2\/MDCK cell monolayers","volume":"194","author":"Ebert","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0035","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.bpj.2018.09.025","article-title":"Passive permeability of planar lipid bilayers to organic anions","volume":"115","author":"Ebert","year":"2018","journal-title":"Biophysj"},{"key":"10.1016\/j.ejps.2025.107354_bib0036","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/aic.690480220","article-title":"Fast solvent screening via quantum chemistry: COSMO-RS approach","volume":"48","author":"Eckert","year":"2002","journal-title":"AIChe J."},{"key":"10.1016\/j.ejps.2025.107354_bib0037","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/etc.4602","article-title":"Recommendations for improving methods and models for aquatic hazard assessment of ionizable organic chemicals","volume":"39","author":"Escher","year":"2020","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.ejps.2025.107354_bib0038","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.drudis.2007.10.005","article-title":"The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity","volume":"12","author":"Fagerholm","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2025.107354_bib0039","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107354_bib0040","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.2042-7158.1997.tb06072.x","article-title":"Molecular factors influencing drug transfer across the blood-brain barrier","volume":"49","author":"Gratton","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107354_bib0041","first-page":"1571","article-title":"Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system","volume":"47","author":"Greig","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0042","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02897227","article-title":"Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat","volume":"26","author":"Greig","year":"1990","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.ejps.2025.107354_bib0043","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005344-199302000-00022","article-title":"Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods","volume":"21","author":"Guillot","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107354_bib0044","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-2952(99)00031-3","article-title":"Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability","volume":"57","author":"Habgood","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107354_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(24)36461-4","article-title":"In vivo and in vitro evidence for nonrestricted transport of 2\u2032,7\u2032-Bis(2-Carboxyethyl)-5(6)-Carboxyfluorescein Tetraacetoxymethyl ester at the blood-b","volume":"280","author":"Hirohashi","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0046","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bjp.0705828","article-title":"The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects","volume":"142","author":"Kavvadias","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107354_bib0047","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/j100007a062","article-title":"Conductor-like screening model for real solvents: a new approach to the quantitative calculation of solvation phenomena","volume":"99","author":"Klamt","year":"1995","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ejps.2025.107354_bib0048","series-title":"Non-Transportable Compounds Through Fundamental Energy Constraints. Preprints","author":"Kotze","year":"2025"},{"key":"10.1016\/j.ejps.2025.107354_bib0049","article-title":"The pH-dependence of efflux ratios determined with bidirectional transport assays across cellular monolayers","volume":"8","author":"Kotze","year":"2024","journal-title":"Int. J. Pharm. X."},{"key":"10.1016\/j.ejps.2025.107354_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-8993(84)91191-0","article-title":"Brain uptake of a food dye, erythrosin B, prevented by plasma protein binding","volume":"322","author":"Levitan","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0051","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/dmd.32.1.132","article-title":"Development of a computational approach to predict blood-brain barrier permeability","volume":"32","author":"Liu","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2025.107354_bib0052","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1021\/acs.jcim.9b00225","article-title":"PerMM: a web tool and database for analysis of passive membrane permeability and translocation pathways of bioactive molecules","volume":"59","author":"Lomize","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejps.2025.107354_bib0053","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-8993(00)02643-3","article-title":"Blood-brain barrier transport studies of organic guanidino cations using an in situ brain perfusion technique","volume":"876","author":"Mahar Doan","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0054","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/cphc.200900270","article-title":"110 years of the meyer-Overton rule: predicting membrane permeability of gases and other small compounds","volume":"10","author":"Missner","year":"2009","journal-title":"Chemphyschem."},{"key":"10.1016\/j.ejps.2025.107354_bib0055","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1152\/ajpheart.2000.279.3.H1022","article-title":"Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique","volume":"279","author":"Murakami","year":"2000","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.ejps.2025.107354_bib0056","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(24)34867-0","article-title":"Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier","volume":"290","author":"Murata","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0057","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11095-006-9149-4","article-title":"Assessment of the first and second generation antihistamines brain penetration and role of P-glycoprotein","volume":"24","author":"Obradovic","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0058","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2025.107354_bib0059","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.lfs.2007.01.035","article-title":"Blood-brain barrier transport of pramipexole, a dopamine D2 agonist","volume":"80","author":"Okura","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neuint.2009.04.018","article-title":"Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study","volume":"55","author":"Ouellet","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejps.2025.107354_bib0061","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.ejps.2025.107354_bib0062","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(25)13060-7","article-title":"Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier","volume":"253","author":"Pardridge","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0063","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3565(25)38458-2","article-title":"Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs","volume":"268","author":"Pardridge","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0064","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11095-006-9905-5","article-title":"Brain uptake of nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin","volume":"23","author":"Parepally","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0065","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/mp2001878","article-title":"Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery","volume":"8","author":"Peura","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107354_bib0066","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/jnc.14117","article-title":"Uptake and metabolism of sulphated steroids by the blood\u2013brain barrier in the adult male rat","volume":"142","author":"Qaiser","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107354_bib0067","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/jm040114b","article-title":"Chemical modification of paclitaxel (taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ","volume":"48","author":"Rice","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107354_bib0068","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0026-895X(24)26466-X","article-title":"New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy","volume":"57","author":"Rousselle","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107354_bib0069","series-title":"The Blood-Brain Barrier: Biology and Research Protocols","first-page":"193","article-title":"A Review of Blood-Brain Barrier Transport Techniques","author":"Smith","year":"2003"},{"key":"10.1016\/j.ejps.2025.107354_bib0070","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1471-4159.1987.tb01039.x","article-title":"Kinetics of neutral amino acid transport across the blood-brain barrier","volume":"49","author":"Smith","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107354_bib0071","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1986.tb27150.x","article-title":"Kinetics of amino acid transport at the blood-brain barrier studied using an in situ brain perfusion technique","volume":"481","author":"SMITH","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0072","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-3565(25)24483-4","article-title":"Transport of amantadine and rimantadine through the blood-brain barrier","volume":"244","author":"Spector","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0073","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.1988.tb02958.x","article-title":"Fatty acid transport through the blood-brain barrier","volume":"50","author":"Spector","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2025.107354_bib0074","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1517\/17425247.3.3.419","article-title":"Drug delivery across the blodd-brain barrier: Why is it difficult? How to measure and improve it?","volume":"3","author":"Su","year":"2006","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107354_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0076","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/jps.10224","article-title":"Investigation of transport mechanism of pentazocine across the blood-brain barrier using the in situ rat brain perfusion technique","volume":"91","author":"Suzuki","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107354_bib0077","article-title":"An in situ brain perfusion technique to study cerebrovascular transport in the rat","volume":"16","author":"Takasato","year":"1984","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.ejps.2025.107354_bib0078","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3565(24)38880-9","article-title":"Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier","volume":"295","author":"Tamai","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0079","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0022-3565(24)38041-3","article-title":"Drug-protein binding and blood-brain barrier permeability","volume":"288","author":"Tanaka","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11095-010-0280-x","article-title":"Physicochemical selectivity of the BBB microenvironment governing passive diffusion - Matching with a porcine brain lipid extract artificial membrane permeability model","volume":"28","author":"Tsinman","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0081","unstructured":"UFZ-LSER database v4.0 [Internet], Leipzig, Germany, Helmholtz Centre for Environmental Research-UFZ. 2025 [accessed on 01.07.2025]. Available from https:\/\/www.ufz.de\/lserd."},{"key":"10.1016\/j.ejps.2025.107354_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42004-021-00528-9","article-title":"Exploring the octanol\u2013water partition coefficient dataset using deep learning techniques and data augmentation","volume":"4","author":"Ulrich","year":"2021","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ejps.2025.107354_bib0083","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/minf.201300030","article-title":"Modeling the biodegradability of chemical compounds using the online chemical modeling environment (OCHEM)","volume":"33","author":"Vorberg","year":"2014","journal-title":"Mol. Inform."},{"key":"10.1016\/j.ejps.2025.107354_bib0084","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01870127","article-title":"Permeability of small nonelectrolytes through lipid bilayer membranes","volume":"90","author":"Walter","year":"1986","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejps.2025.107354_bib0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2004.10.007","article-title":"Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier","volume":"288","author":"Wang","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107354_bib0086","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ejps.2025.107354_bib0087","first-page":"592","article-title":"Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic","volume":"36","author":"Youdim","year":"2004","journal-title":"Biol. Med."},{"key":"10.1016\/j.ejps.2025.107354_bib0088","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","article-title":"The barrier and interface mechanisms of the brain barrier, and brain drug delivery","volume":"190","author":"Zhang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejps.2025.107354_bib0089","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s11095-009-9876-4","article-title":"Assessment of blood-brain barrier permeability using the in situ mouse brain perfusion technique","volume":"26","author":"Zhao","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107354_bib0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/dmd.107.019893","article-title":"Fexofenadine brain exposure and the influence of blood-brain barrier P-glycoprotein after fexofenadine and terfenadine administration","volume":"37","author":"Zhao","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2025.107354_bib0091","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1124\/dmd.108.025064","article-title":"Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrier","volume":"37","author":"Zhao","year":"2009","journal-title":"Drug Metab. Dispos."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:10:31Z","timestamp":1763662231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":91,"alternative-id":["S0928098725003513"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107354","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier permeability revisited: Predicting intrinsic passive BBB permeability using the Solubility-diffusion model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107354"}}